TICKERNOMICS Sign up
Last Update: 2024-12-27 15:26:09
Absci Corp ( ABSI ) https://www.absci.com
2.98USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-35.22%
ABSI
SPY
32.66%
-63.21%
ABSI
SPY
108.59%
ABSI
0.00%
SPY
302.52%
ABSI
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
341.98
217.06
1.87
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-3.50
81.29
1.70
-15.90
0.00
-2.30
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-1698.71
100.00
-1696.57
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
-72.38
-45.15
0.00
Other Earnings and Cash Flow Stats:
Absci Corp ( ABSI ) Net Income TTM ($MM) is -97.67
Absci Corp ( ABSI ) Operating Income TTM ($MM) is -103.35
Absci Corp ( ABSI ) Owners' Earnings Annual ($MM) is 0.00
Absci Corp ( ABSI ) Current Price to Owners' Earnings ratio is 0.00
Absci Corp ( ABSI ) EBITDA TTM ($MM) is -89.71
Absci Corp ( ABSI ) EBITDA Margin is -1696.57%
Capital Allocation:
Absci Corp ( ABSI ) has paid 0.00 dividends per share and bought back -21.396254 million shares in the past 12 months
Absci Corp ( ABSI ) has reduced its debt by 18.422 million USD in the last 12 months
Capital Structure:
Absci Corp ( ABSI ) Interest-bearing Debt ($MM) as of last quarter is 2
Absci Corp ( ABSI ) Annual Working Capital Investments ($MM) are 14
Absci Corp ( ABSI ) Book Value ($MM) as of last quarter is 201
Absci Corp ( ABSI ) Debt/Capital as of last quarter is 1%
Other Balance Sheet Stats:
Absci Corp ( ABSI ) has 38 million in cash on hand as of last quarter
Absci Corp ( ABSI ) has 26 million of liabilities due within 12 months, and long term debt 6 as of last quarter
Absci Corp ( ABSI ) has 113 common shares outstanding as of last quarter
Absci Corp ( ABSI ) has 0 million USD of preferred stock value
Academic Scores:
Absci Corp ( ABSI ) Altman Z-Score is 2.33 as of last quarter
Absci Corp ( ABSI ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
Absci Corp ( ABSI ) largest shareholder is Corebridge Financial, Inc. owning 42701 shares at 0.13 ($MM) value
Jonasson Zachariah(an insider) Sold 19859 shares of Absci Corp ( ABSI ) for the amount of $98891.86 on 2024-06-13
20.09% of Absci Corp ( ABSI ) is held by insiders, and 62.40% is held by institutions
Absci Corp ( ABSI ) went public on 2021-07-22
Other Absci Corp ( ABSI ) financial metrics:
FCF:-70.78
Unlevered Free Cash Flow:0.00
EPS:-0.96
Operating Margin:-1698.71
Gross Profit Margin:100.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-54.43
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Absci Corp ( ABSI ) :
Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.